ロード中...
Sofosbuvir Use in the Setting of End-stage Renal Disease: A Single Center Experience
Background and Aims: Patients with chronic hepatitis C (CHC) and end-stage renal disease (ESRD) who are dialysis-dependent form a unique group, in which safety, tolerability and efficacy of sofosbuvir (SOF)-based direct-acting antivirals (DAAs) need further evaluation. Methods: We performed a retros...
保存先:
| 出版年: | J Clin Transl Hepatol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
XIA & HE Publishing Inc.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5411352/ https://ncbi.nlm.nih.gov/pubmed/28507922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2016.00060 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|